Evoke Pharma Inc is engaged in the development of drugs to treat gastrointestinal disorders and diseases. Its product candidate EVK-001 is in late stage clinical testing.


Updates from The Motley Fool

Latest updates on Evoke Pharma from Fool.com.

There is no available coverage of Evoke Pharma at this time.



Stock Performance

EVOK vs. S&P 500 | 2 Year Performance
View Interactive EVOK Charts
Sponsored by

Key Data Points

Primary metrics and data points about Evoke Pharma.
Current Price: $2.26
Prev Close: $2.19
Open: $2.18
Bid: $2.15
Ask: $2.27
Day's Range: $2.06 - $2.26
52wk Range: $1.52 - $11.11
Volume: 416,655
Avg Vol 495,395
Market Cap: $16M
P/E (ttm): -1.34
EPS (ttm): ($1.63)
Div & Yield: $0.00 (0.0%)

Company Rating

What our community thinks about Evoke Pharma.
CAPS Rating 1 out of 5
 
9 Outperform
7 Underperform
CAPS All Stars
 
3 Outperform
3 Underperform

How do you think Evoke Pharma will perform against the market?



You pick for Evoke Pharma is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS


Business Summary

Industry, sector and description for Evoke Pharma.

Evoke Pharma Inc is engaged in the development of drugs to treat gastrointestinal disorders and diseases. Its product candidate EVK-001 is in late stage clinical testing.

  • Exchange: NASDAQ